SD Biosensor (137310.KS)

SD BioSensor Inc., an in-vitro diagnostic company, provides point-of-care diagnostic solutions in South Korea and internationally. The company's products include STANDARD Q, which provides various rapid test parameters comprising COVID-19 products and other parameters. STANDARD F is a multi-parametric and random accessible FIA system that provides diagnostic results to the laboratories. Additionally, STANDARD E is an enzyme linked immunosorbent assay for mass screening tests. Its products also include STANDARD M, a point-of-care MDx system for clinical decision making near-the-patient, which includes analyzers, assay menus, qPCR reagents, and NA extraction kits. Procell Dx is another product, which includes in vitro diagnostic products for the diagnosis of infectious diseases, such as tuberculosis and SARS-CoV-2, and for checking the immune status of individuals through the interferon gamma release assay. Furthermore, the company offers blood glucose meters. SD BioSensor was founded in 2010 and is headquartered in Suwon, South Korea.